Rossari Biotech Limited (NSE:ROSSARI)
India · Delayed Price · Currency is INR 504.00
-3.55 (-0.70%)
Jul 31, 2026, 3:29 PM IST
Rossari Biotech Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 25,498 | 23,964 | 20,803 | 18,306 | 16,559 | 14,830 |
Revenue Growth | 19.47% | 15.19% | 13.64% | 10.55% | 11.66% | 109.06% |
Gross Profit Gross Profit Growth | 7,529 | 7,189 | 6,410 | 5,298 | 4,794 | 3,708 |
Operating Income Operating Income Growth | 1,949 | 1,900 | 1,872 | 1,827 | 1,516 | 1,292 |
Net Income Net Income Growth | 1,507 | 1,492 | 1,364 | 1,307 | 1,073 | 976.74 |
Earnings Per Share EPS Growth | 27.20 | 26.93 | 24.63 | 23.62 | 19.38 | 17.70 |
EPS Growth | 11.52% | 9.34% | 4.28% | 21.88% | 9.49% | 14.41% |
| Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 17,828 | 15,229 | 13,825 | 12,762 | 12,184 |
outside India outside India Growth | 6,136 | 5,574 | 4,480 | 3,797 | 2,646 |
Total Total Growth | 23,964 | 20,803 | 18,306 | 16,559 | 14,830 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 1,148 | 1,148 | 1,060 | 708.15 | 1,503 | 644.26 |
Total Debt Total Debt Growth | 4,359 | 4,359 | 2,180 | 1,188 | 739.28 | 84.27 |
Net Cash (Debt) Net Cash Growth | -3,211 | -3,211 | -1,120 | -479.77 | 763.29 | 559.99 |
Net Cash Growth | - | - | - | - | 36.30% | -36.62% |
Net Cash Per Share Net Cash Per Share Growth | -57.95 | -57.95 | -20.24 | -8.67 | 13.79 | 10.15 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 650.68 | 1,374 | 432.55 | 1,516 | 293.58 |
Capital Expenditures CapEx Growth | - | -2,647 | -1,585 | -1,313 | -328.76 | -382.25 |
Free Cash Flow Free Cash Flow Growth | - | -1,996 | -210.69 | -880.28 | 1,187 | -88.67 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 29.53% | 30.00% | 30.81% | 28.94% | 28.95% | 25.01% |
Operating Margin | 7.64% | 7.93% | 9.00% | 9.98% | 9.16% | 8.71% |
Pretax Margin | 8.00% | 8.45% | 8.90% | 9.70% | 8.71% | 9.19% |
Profit Margin | 5.91% | 6.23% | 6.56% | 7.14% | 6.48% | 6.59% |
FCF Margin | - | -8.33% | -1.01% | -4.81% | 7.17% | -0.60% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.500 | 0.500 | 0.500 | 0.500 | 0.500 | 0.500 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Dividend Yield | 0.10% | 0.13% | 0.08% | 0.07% | 0.08% | 0.06% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 18.54 | 14.05 | 24.55 | 28.62 | 30.65 | 51.39 |
Forward PE | 17.59 | 13.60 | 21.24 | 24.16 | 21.14 | 32.93 |
P/FCF Ratio | - | - | - | - | 27.70 | - |
PS Ratio | 1.10 | 0.88 | 1.61 | 2.04 | 1.99 | 3.38 |